Neurogene Inc.
Pharmaceutical company · New York, United States · Nasdaq: NGNE
Neurogene Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker NGNE. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2011.
Neurogene at a glance
What does Neurogene do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3.5 million sold (2011).
Frequently asked questions about Neurogene
Where is Neurogene headquartered?
Neurogene Inc. is headquartered in New York, United States.
What does Neurogene do?
Neurogene Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Neurogene a public company?
Yes. Neurogene Inc. trades on Nasdaq under the ticker NGNE.
When was Neurogene founded?
The earliest incorporation on record for Neurogene Inc. is in 2007, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences